Lene Gerlach Ph.D Overview

  • Primary Position
  • Board Observer

  • Primary Industry
  • Healthcare

  • Active Board Seats
  • 2

  • Med. Deal Size

  • Med. Valuation

Lene Gerlach Ph.D General Information

Biography

Dr. Lene Gerlach serves as a Board Observer at Synklino. She also serves as a Board Member at Hoba Therapeutics. She served as a Partner at Eir Ventures. She served as Investment Manager, Early Engagement at VF Venture. She served as Chairperson at EYE-GO. She served as a Board Member at Northern VO. She served as a Board Member at VentriJect. She served as a Board Observer at Cerebriu and Chromologics. She served as a Board Member at Advanced Substrate Technologies. She is a former funds manager at Borean Innovation and has held several board seats throughout her career. Her primary competencies are within the medical field, and she holds a Ph.D. in Neuroscience from Copenhagen University. She served as a Board Member at Airloft. She is a VC specializing in Life Science investments with more than 25 years of experience within the life science industry as a research scientist (with a Ph.D. in Neuroscience), patent attorney, business developer, consultant on university spin-outs, Vice President in two biotech companies and 7 years as a venture capitalist having financed more than 35 companies, prepared follow-up capital rounds and executed company exits. She has extensive board experience having headed 18 companies as Chairman and 17 as a board member or observer. She is an investment manager at Vækstfonden, the Sovereign Wealth Fund of the Danish state.

Contact Information

Primary Position
Board Observer, Synklino
Education
Københavns Universitet, Ph.D. (Doctor of Philosophy)
Københavns Universitet, MS (Master of Science)
Gender
Female
Phone
+45 20
Address
  • Frederiksborggade 1. 2.th.
  • 1360 Copenhagen
  • Denmark
+45 53

Lene Gerlach Ph.D Board Seats (2)

Company Industry Ownership Status Financing Status Location Since
Hoba Therapeutics Drug Discovery Privately Held (backing) Venture Capital-Backed Copenhagen, Denmark
Synklino Drug Discovery Privately Held (backing) Venture Capital-Backed Copenhagen, Denmark

Lene Gerlach Ph.D Lead Partner on Deals (8)

Lene Gerlach Ph.D has been the lead partner on 8 deals. Their latest deal was with Hoba Therapeutics, a drug discovery company. The deal was made for on 11-Dec-2023.

Company Deal Date Deal Type Deal Size Deal Status Industry Location
Hoba Therapeutics 11-Dec-2023 Later Stage VC (Series A) Completed Drug Discovery Copenhagen, Denmark
Dania Therapeutics 18-Oct-2023 Completed Drug Discovery Hellerup, Denmark
Hoba Therapeutics 07-Jul-2022 Completed Drug Discovery Copenhagen, Denmark
CathVision 07-Jul-2017 Completed Diagnostic Equipment Copenhagen, Denmark
Hoba Therapeutics 02-Dec-2016 Completed Drug Discovery Copenhagen, Denmark
Paqle 01-Jun-2014 Completed Information Services (B2C) Copenhagen, Denmark
CathVision Accelerator/Incubator Completed Diagnostic Equipment Copenhagen, Denmark
Northern VO Accelerator/Incubator Completed Other Commercial Services Lyngby, Denmark

Lene Gerlach Ph.D Network (98)

Board Members (76)

Name Company Representing Location From
Jonas Ahm-Lundgren Octarine Bio The Footprint Firm Copenhagen, Denmark
Jarne Elleholm Chromologics Self Copenhagen, Denmark
VentriJect Self Copenhagen, Denmark
Synklino Self Copenhagen, Denmark
Hoba Therapeutics Self Copenhagen, Denmark

Portfolio Executives (17)

Name Company Role Deal date Location
Kenneth Petersen Ph.D Hoba Therapeutics Co-Founder, Chief Operating Officer & CDO 11-Dec-2023 Copenhagen, Denmark
Torsten Madsen Ph.D Hoba Therapeutics Chief Executive Officer 11-Dec-2023 Copenhagen, Denmark
Hoba Therapeutics Chief Scientific Officer 11-Dec-2023 Copenhagen, Denmark
Hoba Therapeutics Chief Financial Officer 11-Dec-2023 Copenhagen, Denmark
Dania Therapeutics Co-Founder & Board Member 18-Oct-2023 Hellerup, Denmark

Fund Team Members (5)

Name Investor Fund Fund Location
Stephan Christgau Ph.D Eir Ventures Eir Ventures Life Science Fund Stockholm, Sweden
Lovisa Backemar Ph.D Eir Ventures Eir Ventures Life Science Fund Stockholm, Sweden
Eir Ventures Stockholm, Sweden
Eir Ventures Stockholm, Sweden
Eir Ventures Stockholm, Sweden

Lene Gerlach Ph.D Affiliated Funds (1)

Fund Investor Fund Type Status Vintage Size Dry Powder IRR IRR Quartile
Eir Ventures Life Science Fund Eir Ventures Venture - General Closed 2020

Lene Gerlach Ph.D FAQs

  • Who is Lene Gerlach Ph.D?

    Dr. Lene Gerlach serves as a Board Observer at Synklino.

  • How much does Lene Gerlach Ph.D typically invest?

    Lene Gerlach Ph.D's median deal size is .

  • What is Lene Gerlach Ph.D’s main position?

    Lene Gerlach Ph.D’s primary position is Board Observer.

  • How many active board seats does Lene Gerlach Ph.D hold?

    Lene Gerlach Ph.D holds 2 board seats including Hoba Therapeutics and Synklino.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »